Non-adherence is one of the most expensive, most invisible problems in healthcare. Patients leave the pharmacy with the right medication, the right dose, and the right intention — and somewhere between the counter and day fourteen, the plan quietly falls apart. After twelve months of patient engagement data from MediActivate’s pharmacy partners across Aotearoa, the pattern is unmistakable.
Most adherence loss doesn’t happen because patients disagree with the treatment. It happens because life gets in the way: a missed dose becomes two, then a week, then a refill that never comes. The good news is that the inflection points are predictable — and a small number of well-timed touchpoints can change the trajectory.
Where adherence actually breaks down
Across long-term medication classes, our data shows three consistent drop-off windows: the first 72 hours after dispense (when side-effect concerns peak), days 10–14 (when the initial routine starts to fray), and the refill-due window at the end of the supply. Each of these is a moment where the patient is making a quiet, often unconscious, decision about whether to continue.
“Adherence isn’t a single decision — it’s a series of small ones, made in the gaps between appointments.”
Two simple touchpoints that move the needle
The interventions don’t need to be sophisticated. In the cohorts we’ve studied, two carefully timed messages — one SMS in the early window and one email near the refill point — consistently lift refill rates and reduce avoidable harm. The content matters less than the timing and the relevance.
- Early SMS (day 2–3) — a short, supportive message reinforcing the “why,” with a clear path back to the prescriber if side effects appear.
- Pre-refill email (day 25–28) — a gentle reminder that connects the next dispense to the patient’s original goal, not just the date on the script.
- Pharmacist-led prompts — when the same patient returns, the pharmacist sees the engagement history and can have a more informed conversation at the counter.
